Download: Replikins whitepaper on preventing influenza pandemics, predicting outbreaks and H5N1 22 October 2012 / By Caroline Hornby / Featured on App, Flu, Prophylactic Vaccines, Reports / 0 comments
Centre de Recherche Clinique Étienne-Le Bel on influenza immunity and virus-host interaction 16 October 2012 / By Caroline Hornby / Flu, Therapeutic Vaccines / 0 comments
Download: AfriVax whitepaper on next-gen technologies for egg-based biopharmaceutical manufacturing 11 October 2012 / By Caroline Hornby / Flu, Reports / 0 comments
Download: Retroscreen Virology paper on preexisting influenza-specific CD4+ T cells and correlation with disease protection 1 October 2012 / By Caroline Hornby / Antibodies, Flu, Reports / 0 comments
Guest blog by EpiVax: Who would want “vaccines on demand?” Ask the mother of a child in Cambodia. 25 September 2012 / By Caroline Hornby / Emerging Markets, Flu, Partnering and Corporate strategy, Regulation and Policy, Therapeutic Vaccines / 0 comments
Download: EpiVax whitepapers on H1N1 influenza vaccines, T cell epitopes and more! 17 September 2012 / By Caroline Hornby / Flu, Reports / 0 comments
MedImmune: The rationale for quadrivalent influenza vaccines 11 September 2012 / By Caroline Hornby / Flu, Prophylactic Vaccines, Regulation and Policy / 0 comments
Download: Whitepapers by Joost Kreijtz of Erasmus Medical Center on MVA-based H5N1 influenza vaccines 5 September 2012 / By Caroline Hornby / Flu, Reports / 0 comments
6 influenza vaccines approved by the FDA 16 August 2012 / By Caroline Hornby / Flu, Regulation and Policy / 0 comments
Universal flu vaccine: recent discovery 13 August 2012 / By Caroline Hornby / Antibodies, Featured on App, Flu, R&D / 1 comment
